1. Home
  2. GRFS vs VSAT Comparison

GRFS vs VSAT Comparison

Compare GRFS & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.84

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$46.17

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
VSAT
Founded
1940
1986
Country
Spain
United States
Employees
25247
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.6B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
GRFS
VSAT
Price
$7.84
$46.17
Analyst Decision
Hold
Buy
Analyst Count
2
6
Target Price
$10.15
$43.60
AVG Volume (30 Days)
682.6K
1.2M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
1.79%
N/A
EPS Growth
N/A
50.88
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.33
$5.34
Revenue Next Year
$6.50
$3.59
P/E Ratio
$18.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.19
$7.36
52 Week High
$11.14
$50.24

Technical Indicators

Market Signals
Indicator
GRFS
VSAT
Relative Strength Index (RSI) 27.72 51.43
Support Level $7.64 $41.76
Resistance Level $9.11 $49.81
Average True Range (ATR) 0.29 2.88
MACD -0.12 -0.24
Stochastic Oscillator 2.99 40.24

Price Performance

Historical Comparison
GRFS
VSAT

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

Share on Social Networks: